aluates Reports

$ 0.0

Automative

Global Generic Injectables Market Research Report 2024

Published Date: March 2024

Report Code: QYRE-Auto-32B9066

Global Generic Injectables Market Insights and Forecast to 2028

BUY CHAPTERS

Global Generic Injectables Market Research Report 2024

Code: QYRE-Auto-32B9066

Report

March 2024

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Hospira (Pfizer Inc.)

Fresenius Kabi

Sandoz(Novartis)

Hikma Pharmaceuticals PLC

Dr. Reddy’s Laboratories Ltd.

Grifols S A

Nichi-Iko Group (Sagent)

Teva Pharmaceutical

AuroMedics

Sanofi

Gland Pharma

Endo International Plc.

Generic Injectables Market Size

The global Generic Injectables market was valued at US$ 30610 million in 2023 and is anticipated to reach US$ 39060 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.

Generic Injectables Market

Generic injectables refer to sterile solutions (including emulsions and suspensions) made of drugs for injection into the body, and sterile powders or concentrated solutions that are prepared into solutions or suspensions before use.

The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. It is suitable for patients who are not suitable for oral medicine and patients who cannot be taken orally. However, the development and production process of injections is complicated and safe. The body has poor adaptability and high cost.

In the segment of generic sterile injectables, the Hospira (Pfizer Inc.) is the largest player, and Fresenius Kabi is the second. Top two players hold a share about 27% in 2019. The US market is dominated by two players like Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, Gland Pharma and Endo International PLC.

This report aims to provide a comprehensive presentation of the global market for Generic Injectables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Injectables.

Report Scope

The Generic Injectables market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Generic Injectables market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Generic Injectables companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Generic Injectables Market Report

Report Metric	Details
Report Name	Generic Injectables Market
Accounted market size in 2023	US$ 30610 million
Forecasted market size in 2030	US$ 39060 million
CAGR	3.5%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Small Molecule Large Molecule
Segment by Application	Oncology Anesthesia Anti-Infectives Parenteral Nutrition Cardiovascular Diseases
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, Gland Pharma, Endo International PLC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Generic Injectables companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Generic Injectables Market growing?

Ans: The Generic Injectables Market witnessing a CAGR of 3.5% during the forecast period 2024-2030.

What is the Generic Injectables Market size in 2030?

Ans: The Generic Injectables Market size in 2030 will be US$ 39060 million.

What is the market share of major companies in Generic Injectables Market?

Ans: Top two players hold a share about 27% in 2019.

Who are the main players in the Generic Injectables Market report?

Ans: The main players in the Generic Injectables Market are Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, Gland Pharma, Endo International PLC

What are the Application segmentation covered in the Generic Injectables Market report?

Ans: The Applications covered in the Generic Injectables Market report are Oncology, Anesthesia, Anti-Infectives, Parenteral Nutrition, Cardiovascular Diseases

What are the Type segmentation covered in the Generic Injectables Market report?

Ans: The Types covered in the Generic Injectables Market report are Small Molecule, Large Molecule

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Generic Injectables Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Small Molecule

1.2.3 Large Molecule

1.3 Market by Application

1.3.1 Global Generic Injectables Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Oncology

1.3.3 Anesthesia

1.3.4 Anti-Infectives

1.3.5 Parenteral Nutrition

1.3.6 Cardiovascular Diseases

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Generic Injectables Market Perspective (2019-2030)

2.2 Generic Injectables Growth Trends by Region

2.2.1 Global Generic Injectables Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Generic Injectables Historic Market Size by Region (2019-2024)

2.2.3 Generic Injectables Forecasted Market Size by Region (2025-2030)

2.3 Generic Injectables Market Dynamics

2.3.1 Generic Injectables Industry Trends

2.3.2 Generic Injectables Market Drivers

2.3.3 Generic Injectables Market Challenges

2.3.4 Generic Injectables Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Generic Injectables Players by Revenue

3.1.1 Global Top Generic Injectables Players by Revenue (2019-2024)

3.1.2 Global Generic Injectables Revenue Market Share by Players (2019-2024)

3.2 Global Generic Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Generic Injectables Revenue

3.4 Global Generic Injectables Market Concentration Ratio

3.4.1 Global Generic Injectables Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Generic Injectables Revenue in 2023

3.5 Generic Injectables Key Players Head office and Area Served

3.6 Key Players Generic Injectables Product Solution and Service

3.7 Date of Enter into Generic Injectables Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Generic Injectables Breakdown Data by Type

4.1 Global Generic Injectables Historic Market Size by Type (2019-2024)

4.2 Global Generic Injectables Forecasted Market Size by Type (2025-2030)

5 Generic Injectables Breakdown Data by Application

5.1 Global Generic Injectables Historic Market Size by Application (2019-2024)

5.2 Global Generic Injectables Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Generic Injectables Market Size (2019-2030)

6.2 North America Generic Injectables Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Generic Injectables Market Size by Country (2019-2024)

6.4 North America Generic Injectables Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Generic Injectables Market Size (2019-2030)

7.2 Europe Generic Injectables Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Generic Injectables Market Size by Country (2019-2024)

7.4 Europe Generic Injectables Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Generic Injectables Market Size (2019-2030)

8.2 Asia-Pacific Generic Injectables Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Generic Injectables Market Size by Region (2019-2024)

8.4 Asia-Pacific Generic Injectables Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Generic Injectables Market Size (2019-2030)

9.2 Latin America Generic Injectables Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Generic Injectables Market Size by Country (2019-2024)

9.4 Latin America Generic Injectables Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Generic Injectables Market Size (2019-2030)

10.2 Middle East & Africa Generic Injectables Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Generic Injectables Market Size by Country (2019-2024)

10.4 Middle East & Africa Generic Injectables Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Hospira (Pfizer Inc.)

11.1.1 Hospira (Pfizer Inc.) Company Detail

11.1.2 Hospira (Pfizer Inc.) Business Overview

11.1.3 Hospira (Pfizer Inc.) Generic Injectables Introduction

11.1.4 Hospira (Pfizer Inc.) Revenue in Generic Injectables Business (2019-2024)

11.1.5 Hospira (Pfizer Inc.) Recent Development

11.2 Fresenius Kabi

11.2.1 Fresenius Kabi Company Detail

11.2.2 Fresenius Kabi Business Overview

11.2.3 Fresenius Kabi Generic Injectables Introduction

11.2.4 Fresenius Kabi Revenue in Generic Injectables Business (2019-2024)

11.2.5 Fresenius Kabi Recent Development

11.3 Sandoz (Novartis)

11.3.1 Sandoz (Novartis) Company Detail

11.3.2 Sandoz (Novartis) Business Overview

11.3.3 Sandoz (Novartis) Generic Injectables Introduction

11.3.4 Sandoz (Novartis) Revenue in Generic Injectables Business (2019-2024)

11.3.5 Sandoz (Novartis) Recent Development

11.4 Hikma Pharmaceuticals PLC

11.4.1 Hikma Pharmaceuticals PLC Company Detail

11.4.2 Hikma Pharmaceuticals PLC Business Overview

11.4.3 Hikma Pharmaceuticals PLC Generic Injectables Introduction

11.4.4 Hikma Pharmaceuticals PLC Revenue in Generic Injectables Business (2019-2024)

11.4.5 Hikma Pharmaceuticals PLC Recent Development

11.5 Dr. Reddy’s Laboratories Ltd

11.5.1 Dr. Reddy’s Laboratories Ltd Company Detail

11.5.2 Dr. Reddy’s Laboratories Ltd Business Overview

11.5.3 Dr. Reddy’s Laboratories Ltd Generic Injectables Introduction

11.5.4 Dr. Reddy’s Laboratories Ltd Revenue in Generic Injectables Business (2019-2024)

11.5.5 Dr. Reddy’s Laboratories Ltd Recent Development

11.6 Grifols

11.6.1 Grifols Company Detail

11.6.2 Grifols Business Overview

11.6.3 Grifols Generic Injectables Introduction

11.6.4 Grifols Revenue in Generic Injectables Business (2019-2024)

11.6.5 Grifols Recent Development

11.7 Nichi-Iko Group (Sagent)

11.7.1 Nichi-Iko Group (Sagent) Company Detail

11.7.2 Nichi-Iko Group (Sagent) Business Overview

11.7.3 Nichi-Iko Group (Sagent) Generic Injectables Introduction

11.7.4 Nichi-Iko Group (Sagent) Revenue in Generic Injectables Business (2019-2024)

11.7.5 Nichi-Iko Group (Sagent) Recent Development

11.8 Teva Pharmaceutical

11.8.1 Teva Pharmaceutical Company Detail

11.8.2 Teva Pharmaceutical Business Overview

11.8.3 Teva Pharmaceutical Generic Injectables Introduction

11.8.4 Teva Pharmaceutical Revenue in Generic Injectables Business (2019-2024)

11.8.5 Teva Pharmaceutical Recent Development

11.9 Auromedics

11.9.1 Auromedics Company Detail

11.9.2 Auromedics Business Overview

11.9.3 Auromedics Generic Injectables Introduction

11.9.4 Auromedics Revenue in Generic Injectables Business (2019-2024)

11.9.5 Auromedics Recent Development

11.10 Sanofi

11.10.1 Sanofi Company Detail

11.10.2 Sanofi Business Overview

11.10.3 Sanofi Generic Injectables Introduction

11.10.4 Sanofi Revenue in Generic Injectables Business (2019-2024)

11.10.5 Sanofi Recent Development

11.11 Gland Pharma

11.11.1 Gland Pharma Company Detail

11.11.2 Gland Pharma Business Overview

11.11.3 Gland Pharma Generic Injectables Introduction

11.11.4 Gland Pharma Revenue in Generic Injectables Business (2019-2024)

11.11.5 Gland Pharma Recent Development

11.12 Endo International PLC

11.12.1 Endo International PLC Company Detail

11.12.2 Endo International PLC Business Overview

11.12.3 Endo International PLC Generic Injectables Introduction

11.12.4 Endo International PLC Revenue in Generic Injectables Business (2019-2024)

11.12.5 Endo International PLC Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Hospira (Pfizer Inc.)

Fresenius Kabi

Sandoz(Novartis)

Hikma Pharmaceuticals PLC

Dr. Reddy’s Laboratories Ltd.

Grifols S A

Nichi-Iko Group (Sagent)

Teva Pharmaceutical

AuroMedics

Sanofi

Gland Pharma

Endo International Plc.

List of Tables

Table 1. Global Generic Injectables Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Small Molecule

Table 3. Key Players of Large Molecule

Table 4. Global Generic Injectables Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Generic Injectables Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Generic Injectables Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Generic Injectables Market Share by Region (2019-2024)

Table 8. Global Generic Injectables Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Generic Injectables Market Share by Region (2025-2030)

Table 10. Generic Injectables Market Trends

Table 11. Generic Injectables Market Drivers

Table 12. Generic Injectables Market Challenges

Table 13. Generic Injectables Market Restraints

Table 14. Global Generic Injectables Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Generic Injectables Market Share by Players (2019-2024)

Table 16. Global Top Generic Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injectables as of 2023)

Table 17. Ranking of Global Top Generic Injectables Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Generic Injectables Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Generic Injectables Product Solution and Service

Table 21. Date of Enter into Generic Injectables Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Generic Injectables Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Generic Injectables Revenue Market Share by Type (2019-2024)

Table 25. Global Generic Injectables Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Generic Injectables Revenue Market Share by Type (2025-2030)

Table 27. Global Generic Injectables Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Generic Injectables Revenue Market Share by Application (2019-2024)

Table 29. Global Generic Injectables Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Generic Injectables Revenue Market Share by Application (2025-2030)

Table 31. North America Generic Injectables Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Generic Injectables Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Generic Injectables Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Generic Injectables Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Generic Injectables Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Generic Injectables Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Generic Injectables Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Generic Injectables Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Generic Injectables Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Generic Injectables Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Generic Injectables Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Generic Injectables Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Generic Injectables Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Generic Injectables Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Generic Injectables Market Size by Country (2025-2030) & (US$ Million)

Table 46. Hospira (Pfizer Inc.) Company Detail

Table 47. Hospira (Pfizer Inc.) Business Overview

Table 48. Hospira (Pfizer Inc.) Generic Injectables Product

Table 49. Hospira (Pfizer Inc.) Revenue in Generic Injectables Business (2019-2024) & (US$ Million)

Table 50. Hospira (Pfizer Inc.) Recent Development

Table 51. Fresenius Kabi Company Detail

Table 52. Fresenius Kabi Business Overview

Table 53. Fresenius Kabi Generic Injectables Product

Table 54. Fresenius Kabi Revenue in Generic Injectables Business (2019-2024) & (US$ Million)

Table 55. Fresenius Kabi Recent Development

Table 56. Sandoz (Novartis) Company Detail

Table 57. Sandoz (Novartis) Business Overview

Table 58. Sandoz (Novartis) Generic Injectables Product

Table 59. Sandoz (Novartis) Revenue in Generic Injectables Business (2019-2024) & (US$ Million)

Table 60. Sandoz (Novartis) Recent Development

Table 61. Hikma Pharmaceuticals PLC Company Detail

Table 62. Hikma Pharmaceuticals PLC Business Overview

Table 63. Hikma Pharmaceuticals PLC Generic Injectables Product

Table 64. Hikma Pharmaceuticals PLC Revenue in Generic Injectables Business (2019-2024) & (US$ Million)

Table 65. Hikma Pharmaceuticals PLC Recent Development

Table 66. Dr. Reddy’s Laboratories Ltd Company Detail

Table 67. Dr. Reddy’s Laboratories Ltd Business Overview

Table 68. Dr. Reddy’s Laboratories Ltd Generic Injectables Product

Table 69. Dr. Reddy’s Laboratories Ltd Revenue in Generic Injectables Business (2019-2024) & (US$ Million)

Table 70. Dr. Reddy’s Laboratories Ltd Recent Development

Table 71. Grifols Company Detail

Table 72. Grifols Business Overview

Table 73. Grifols Generic Injectables Product

Table 74. Grifols Revenue in Generic Injectables Business (2019-2024) & (US$ Million)

Table 75. Grifols Recent Development

Table 76. Nichi-Iko Group (Sagent) Company Detail

Table 77. Nichi-Iko Group (Sagent) Business Overview

Table 78. Nichi-Iko Group (Sagent) Generic Injectables Product

Table 79. Nichi-Iko Group (Sagent) Revenue in Generic Injectables Business (2019-2024) & (US$ Million)

Table 80. Nichi-Iko Group (Sagent) Recent Development

Table 81. Teva Pharmaceutical Company Detail

Table 82. Teva Pharmaceutical Business Overview

Table 83. Teva Pharmaceutical Generic Injectables Product

Table 84. Teva Pharmaceutical Revenue in Generic Injectables Business (2019-2024) & (US$ Million)

Table 85. Teva Pharmaceutical Recent Development

Table 86. Auromedics Company Detail

Table 87. Auromedics Business Overview

Table 88. Auromedics Generic Injectables Product

Table 89. Auromedics Revenue in Generic Injectables Business (2019-2024) & (US$ Million)

Table 90. Auromedics Recent Development

Table 91. Sanofi Company Detail

Table 92. Sanofi Business Overview

Table 93. Sanofi Generic Injectables Product

Table 94. Sanofi Revenue in Generic Injectables Business (2019-2024) & (US$ Million)

Table 95. Sanofi Recent Development

Table 96. Gland Pharma Company Detail

Table 97. Gland Pharma Business Overview

Table 98. Gland Pharma Generic Injectables Product

Table 99. Gland Pharma Revenue in Generic Injectables Business (2019-2024) & (US$ Million)

Table 100. Gland Pharma Recent Development

Table 101. Endo International PLC Company Detail

Table 102. Endo International PLC Business Overview

Table 103. Endo International PLC Generic Injectables Product

Table 104. Endo International PLC Revenue in Generic Injectables Business (2019-2024) & (US$ Million)

Table 105. Endo International PLC Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Generic Injectables Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Generic Injectables Market Share by Type: 2023 VS 2030

Figure 3. Small Molecule Features

Figure 4. Large Molecule Features

Figure 5. Global Generic Injectables Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Generic Injectables Market Share by Application: 2023 VS 2030

Figure 7. Oncology Case Studies

Figure 8. Anesthesia Case Studies

Figure 9. Anti-Infectives Case Studies

Figure 10. Parenteral Nutrition Case Studies

Figure 11. Cardiovascular Diseases Case Studies

Figure 12. Generic Injectables Report Years Considered

Figure 13. Global Generic Injectables Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Generic Injectables Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Generic Injectables Market Share by Region: 2023 VS 2030

Figure 16. Global Generic Injectables Market Share by Players in 2023

Figure 17. Global Top Generic Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injectables as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Generic Injectables Revenue in 2023

Figure 19. North America Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Generic Injectables Market Share by Country (2019-2030)

Figure 21. United States Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Generic Injectables Market Share by Country (2019-2030)

Figure 25. Germany Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Generic Injectables Market Share by Region (2019-2030)

Figure 33. China Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Generic Injectables Market Share by Country (2019-2030)

Figure 41. Mexico Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Generic Injectables Market Share by Country (2019-2030)

Figure 45. Turkey Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Generic Injectables Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Hospira (Pfizer Inc.) Revenue Growth Rate in Generic Injectables Business (2019-2024)

Figure 48. Fresenius Kabi Revenue Growth Rate in Generic Injectables Business (2019-2024)

Figure 49. Sandoz (Novartis) Revenue Growth Rate in Generic Injectables Business (2019-2024)

Figure 50. Hikma Pharmaceuticals PLC Revenue Growth Rate in Generic Injectables Business (2019-2024)

Figure 51. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Generic Injectables Business (2019-2024)

Figure 52. Grifols Revenue Growth Rate in Generic Injectables Business (2019-2024)

Figure 53. Nichi-Iko Group (Sagent) Revenue Growth Rate in Generic Injectables Business (2019-2024)

Figure 54. Teva Pharmaceutical Revenue Growth Rate in Generic Injectables Business (2019-2024)

Figure 55. Auromedics Revenue Growth Rate in Generic Injectables Business (2019-2024)

Figure 56. Sanofi Revenue Growth Rate in Generic Injectables Business (2019-2024)

Figure 57. Gland Pharma Revenue Growth Rate in Generic Injectables Business (2019-2024)

Figure 58. Endo International PLC Revenue Growth Rate in Generic Injectables Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions